Wednesday, February 11, 2009

Pfizer Discloses Payment Information for Clinical Trials

According to this article on Pfizer will disclose payments made to principal investigators, major academic institutions and research sites involved in Phase I to IV trials that exceed $500 a year and non-monetary items such as meals that cost more than $25.

Pfizer is getting closer than any drug maker in terms of full disclosure, but if the Physician Payments Sunshine Act of 2009 is passed into law, it would require companies to disclose all payments exceeding $100 a year and would face a fine of up to $1 million if they do not comply.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment